Chronic lymphocytic leukemia: The pathologist's view of lymph node microenvironment

Seminars in Diagnostic Pathology

Volumn 28, Issue 2, 2011, Pages 161-166

  Ponzoni, Maurilio ^a   Doglioni, Claudio ^a   Caligaris Cappio, Federico ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chronic lymphocytic leukemia; Lymphocyte; Microenvironment; Proliferation centers; Stroma; Vessels

Indexed keywords

B LYMPHOCYTE RECEPTOR;

ARTICLE; BLOOD VESSEL; CANCER GROWTH; CANCER INFILTRATION; CELL INTERACTION; CELL ULTRASTRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; LEUKEMOGENESIS; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATION CENTER; STROMA CELL; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; PATHOLOGY; TUMOR MICROENVIRONMENT;

EID: 79958008875     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2011.02.014     Document Type: Article

References (53)

1. Burger J.A., Ghia P., Rosenwald A., et al. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009, 114:3367-3675.
2. Bahler D.W., Aguilera N.S., Chen C.C., et al. Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types. Am J Pathol 2000, 157:1063-1070.
3. Muller-Hermelink H.K., Montserrat E., Catovsky D. Chronic lymphocytic leukemia/small lymphocytic lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 180-182. IARC, Lyon. S.H. Swerdlow (Ed.).
4. Giné E., Martinez A., Villamor N., et al. Expanded and highly active proliferation centres identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 2010, 95:1526-1533.
5. Caligaris-Cappio F., Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?. J Clin Oncol 2008, 26:4497-4503.
6. Muzio M., Bertilaccio M.T.S., Simonetti G., et al. The role of Toll-like receptors in chronic B-cell malignancies. Leuk Lymphoma 2009, 50:1573-1580.
7. Stevenson F.K., Caligaris-Cappio F. Chronic lymphocytic leukemia: Revelations from the B-cell receptor. Blood 2004, 103:4389-4395.
8. Herishanu Y., Pérez-Galán P., Liu D., et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011, 117:563-574.
9. Sebestyén A., Kovalszky I., Mihalik R., et al. Expression of syndecan-1 in human B cell chronic lymphocytic leukemia. Eur J Cancer 1997, 13:2273-2277.
10. Caligaris-Cappio F., Hamblin T.J. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999, 17:399-408.
11. Ghia P., Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res 2000, 79:157-173.
12. Granziero L., Circosta P., Scielzo C., et al. CD100/plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 2003, 101:1962-1969.
13. Pleyer L., Egle A., Hartmann T.N., et al. Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat Rev Clin Oncol 2009, 6:405-418.
14. Burger J.A., Quiroga M.P., Hartmann E., et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell coculture after BCR stimulation. Blood 2009, 113:3050-3058.
15. Zucchetto A., Benedetti D., Tripodo C., et al. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res 2009, 69:4001-4009.
16. Fukuda T., Chen L., Endo T., et al. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Prot Natl Acad Sci USA 2008, 105:3047-3052.
17. Pedersen I.M., Kitada S., Leoni L.M., et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002, 100:1795-1801.
18. De Totero D., Meazza R., Rupo S., et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 2006, 107:3708-3715.
19. Cuní S., Pérez-Aciego P., Pérez-Chacón G., et al. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004, 18:1391-1400.
20. Redondo-Muñoz J., José Terol M., García-Marco J.A., et al. Matrix-metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 2008, 111:383-386.
21. Ramsay A.G., Johnson A.J., Lee A.M., et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest 2008, 118:2427-2437.
22. Ranheim E.A., Cantwell M.J., Kipps T.J. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 1995, 85:3556-3565.
23. Kato K., Chu P., Takahashi S., et al. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp Hematol 2007, 35:434-442.
24. Kato K., Cantwell M.J., Sharma S., et al. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998, 101:133-1141.
25. Richardson S.J., Matthews C., Catherwood M.A., et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 2006, 107:3584-3592.
26. Dierks C., Grbic J., Zirlic K., et al. Essential role of stromally induced hedgehog signalling in B-cell signalling. Nat Med 2007, 13:944-951.
27. Hegde G.V., Peterson K.J., Emanuel K., et al. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal microenvironment: a potential new therapeutic target. Mol Cancer Res 2008, 6:1928-1936.
28. Ghia P., Guida G., Stella S., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 2003, 101:1262-1269.
29. Vincent A.M., Cawley J.C., Burthem J. Integrin function in chronic lymphocytic leukemia. Blood 1996, 87:4780-4788.
30. Till K.J., Spiller D.G., Harris R.J., et al. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium. Blood 2005, 105:4813-4819.
31. Deaglio S., Malavasi F. Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation. Haematologica 2009, 94:752-756.
32. Nakamura N., Hase H., Sakurai D., et al. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody. Virchows Arch 2005, 447:53-60.
33. M'Hidi H., Thibult M.L., Chetaille B., et al. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Am J Clin Pathol 2009, 132:589-596.
34. Xerri L., Chetaille B., Serriari N., et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008, 39:1050-1058.
35. Muenst S., Hoeller S., Willi N., et al. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers 2010, 29:47-53.
36. Burkle A., Niedermeier M., Schmitt-Graff A., et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007, 110:3316-3325.
37. - monocyted-derived cells in diffuse large B-cell lymphomas. Hum Pathol 2006, 37:68-77.
38. Tsukada N., Burger J.A., Zvaifler N.J., et al. Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia. Blood 2002, 99:1030-1037.
39. Ruan J., Hyjek E., Kermani P., et al. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. Clin Cancer Res 2006, 12:5622-5631.
40. Spessotto P., Zucchetto A., Degan M., et al. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. Matrix Biol 2007, 26:473-484.
41. Molica S., Vacca A., Ribatti D., et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002, 100:3344-3351.
42. Soma L.A., Craig F.E., Swerdlow S.H. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 2006, 37:152-159.
43. Zuckerberg L.R., Benedict W.F., Arnold A., et al. Expression of the retinoblastoma protein in low-grade B-cell lymphoma; relationship to cyclin D1. Blood 1996, 88:268-276.
44. Patten P.E.M., Buggins A.G.S., Richards J., et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 2008, 111:5173-5181.
45. O'Malley D.P., Vance G.H., Orazi A. Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin D1 expression: a potential diagnostic pitfall. Arch Pathol Lab Med 2005, 129:92-95.
46. Granziero L., Ghia P., Circosta P., et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001, 97:2777-2783.
47. Willimott S., Baou M., Naresh K., et al. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. Br J Haematol 2007, 138:721-732.
48. Inamdar K.V., O'Brien S., Sen S., et al. Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Mod Pathol 2008, 21:1428-1435.
49. Lampert I.A., Wotherspoon A., Van Noorden S., et al. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. Hum Pathol 1999, 30:648-654.
50. Fournier S., Rubio M., Delespesse G., et al. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994, 84:1881-1886.
51. Isobe K., Tamaru J., Uno T., et al. Immunoglobulin heavy chain variable region (VH) genes of B cell chronic lymphocytic leukemia cells from lymph nodes show somatic mutations and intraclonal diversity irrespective of follicular dendritic cell network. Leuk Lymphoma 2001, 42:499-506.
52. Backman E., Bergh A-C., Lagerdhal I., et al. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro. Haematologica 2007, 92:1495-1504.
53. Ghia P., Strola G., Granziero L., et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 2002, 32:1403-1413.